SINCE MEDICARE OFFICIALS PUBLISHED the final rule for lab test market price reporting of private payer prices last year, clinical lab industry consultants and lawyers have raised serious criticisms of the rule. The critics recognized that CMS officials wrote a final rule for the Protecting Access to Medicare Act (PAMA) that excluded from reporting large […]
- Legal Update
Labs Ask: Does PAMA Statute Prevent Legal Challenges?
Although the law prevents labs from challenging its provisions, avenues of challenge are possible
- By Joseph Burns
- > From the Volume XXIV No. 4 - March 13, 2017 Issue
- Tags: cap, clinical lab, clinical lab fee schedule, clinical labs, dark report, lab administrator, lab industry, lab test, laboratories, laboratory association, Medicare, Medicare Part B, national independent laboratory association, pathologists, private payer, Protecting Access to Medicare Act (PAMA), the dark report
